CP
SHACW

Centerbridge Partners’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Centerbridge Partners’s Portfolio SHACW Stock Details SHACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$2K – 30
2022
Q3 		$2K Hold
50,000
– – ﹤0.01% 32
2022
Q2 		$4K Hold
50,000
– – ﹤0.01% 32
2022
Q1 		$8K Hold
50,000
– – ﹤0.01% 37
2021
Q4 		$28K Hold
50,000
– – ﹤0.01% 48
2021
Q3 		$29K Hold
50,000
– – ﹤0.01% 46
2021
Q2 		$42K Hold
50,000
– – ﹤0.01% 48
2021
Q1 		$30K Buy
+50,000
New +$30.7K ﹤0.01% 48

Centerbridge Partners's SHACW Position: Q4 2022 in Review

Centerbridge Partners sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 50,000 shares — an estimated $2K sold.

Centerbridge Partners first reported a position in SHACW in Q1 2021 and held it in 7 quarters. The position peaked at $42K in Q2 2021. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

  • Centerbridge Partners reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
  • Centerbridge Partners sold 50,000 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $2K.
  • Centerbridge Partners first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 7 quarters.
  • Centerbridge Partners's SCP & CO Healthcare Acquisition Company Warrant position peaked at $42K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Centerbridge Partners's 13F filing for Q4 2022, filed 14 Feb 2023.